The characteristics of invasive breast cancer in women who use and do not use hormone replacement therapy in the million women study.
Gathani T. et al, (2006), BREAST CANCER RESEARCH AND TREATMENT, 100, S232 - S232
Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC).
Chen Z. et al, (2005), Int J Epidemiol, 34, 1243 - 1249
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Abe O. et al, (2005), The Lancet, 366, 2087 - 2106
Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.
Lewington S. and Clarke R., (2005), Circulation, 112, 3373 - 3374
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
Chen ZM. et al, (2005), Lancet, 366, 1607 - 1621
Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
Chen ZM. et al, (2005), Lancet, 366, 1622 - 1632
Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk
Lewington S. and Clarke R., (2005), Circulation, 112, 3373 - 3374
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
Fibrinogen Studies Collaboration None. et al, (2005), JAMA, 294, 1799 - 1809
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis
Danesh J. et al, (2005), Journal of the American Medical Association, 294, 1799 - 1809
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Baigent C. et al, (2005), Lancet, 366, 1267 - 1278
Body fatness and physical activity at young ages and the risk of breast cancer in premenopausal women.
Magnusson CMK. et al, (2005), Br J Cancer, 93, 817 - 824
Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials.
Homocysteine Lowering Trialists' Collaboration None., (2005), Am J Clin Nutr, 82, 806 - 812
Worldwide meta-analyses of breast cancer treatment - EBCTCG 2005 - an update
Peto R., (2005), EJC SUPPLEMENTS, 3, 3 - 3
Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
Cogliano V. et al, (2005), Lancet Oncol, 6, 552 - 553
Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.
Darby SC. et al, (2005), Lancet Oncol, 6, 557 - 565
Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women.
Beral V. et al, (2005), BJOG, 112, 692 - 695
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Abe O. et al, (2005), Lancet, 365, 1687 - 1717
Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V. et al, (2005), Lancet, 365, 1543 - 1551
Reproducibility of a short semi-quantitative food group questionnaire and its performance in estimating nutrient intake compared with a 7-day diet diary in the Million Women Study.
Roddam AW. et al, (2005), Public Health Nutr, 8, 201 - 213
Risk of breast cancer after miscarriage or induced abortion: a Scottish record linkage case-control study.
Brewster DH. et al, (2005), J Epidemiol Community Health, 59, 283 - 287